The Trump administration’s plan to address the opioid crisis focuses on preventing overdose deaths, but neglects the ...

How could a non-opioid painkiller improve the lives of people with chronic pain? What makes a non-opioid painkiller safer ...

The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While questions remain about its cost, adoption, and long-term efficacy, its novel ...

This crisis doesn’t discriminate. It affects working parents, young people and seniors — many of whom end up dependent ...

New research highlights how the brain’s own chemistry can suppress pain, explaining why severely injured individuals, like WWII soldiers, sometimes feel little discomfort.

The hope is that a new generation of non-opioid analgesics will become available to treat both acute and chronic pain and have a reduced risk of addiction. In 2023, more than 100,000 lives were ...

A non-opioid drug for pain developed by UK biotech Levicept, with a new mechanism of action, has shown it can reduce pain associated with osteoarthritis in a phase 2 trial. Neurotrophin-3 (NT-3 ...

Pacira Biosciences has authorized a share buyback program of up to $300 million. The developer of non-opioid pain relievers said Thursday the repurchase program replaces a previous $150 million ...